TGFB1 and colorectal carcinoma: Expanding on this, we developed AI-HOPE-TGFbeta (Yang et al., 2025a), the first pathway-specific conversational agent focused on interrogating TGF-β alterations in CRC, demonstrating the platform’s ability to replicate known findings and stratify patients across clinical variables.